Clin2
NCT07368608Possibly a fitRecruiting

Testing a new drug for high blood pressure and cholesterol

Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol

Part of Heart & circulation, Hormones & metabolism clinical trials.

This study tests a new medicine called BEBT-701 for people with mild to moderate high blood pressure and high cholesterol. The goal is to see if it can lower both blood pressure and LDL ('bad') cholesterol safely.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
340 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are between 18 and 60 years old.
  • You have high blood pressure and are not currently taking medication for it (or have been off it for at least 30 days).
  • Your LDL cholesterol is between 100 and 190 mg/dL (or 2.6 and 4.9 mmol/L).
  • You have a stable diet and body weight, and you are willing to keep them stable during the study.
  • You are willing to use highly effective birth control and avoid pregnancy or fathering a child for 12 months after the last dose.
  • You do not have serious health conditions like heart disease, diabetes, kidney problems, or a history of cancer in the last 5 years.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07654140Recruiting· Phase 2
Testing a new drug for uncontrolled high blood pressure

This trial tests a new drug called SAL0140 for people whose high blood pressure is not controlled by current treatments. It may help lower blood pressure when other medications haven't worked well enough.

Beijing, Beijing Municipality
NCT07074236Not yet recruiting· Phase 1
Study of a new cholesterol drug in healthy adults

This study tests how a new drug moves through the body and affects cholesterol levels. It is for people with moderately high cholesterol who are otherwise healthy.

Qingdao
NCT07373613Not yet recruiting· Phase 2
Testing new drugs for high blood pressure

This trial tests five new medications to see how well they lower blood pressure in people with essential hypertension (high blood pressure with no known cause). Participants will temporarily stop their current blood pressure medicine during the study.

Soeul
NCT07230730Recruiting· Phase 3
Testing a new drug for high cholesterol

This trial tests a new medication called SHR-1918 for people with high cholesterol who are already on statins. The goal is to see if it can further lower cholesterol and improve health.

Hangzhou, Zhejiang
NCT07352969Not yet recruiting· Phase 2
Testing a new hypertension drug in mild to moderate patients

This trial tests a new medicine called IBI3016 for people with mild to moderate high blood pressure. It aims to find the right dose to safely lower blood pressure without other blood pressure medications.

Beijing, Beijing Municipality
NCT06917482Recruiting· Phase 1
Testing a new drug called BW-40202 in healthy people

This study tests a new medicine called BW-40202 for the first time in people. It is for healthy volunteers to see if the drug is safe and how it works in the body. You must be in good general health to take part.

Brisbane, Queensland

Hear when a new Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.